Dr. John Blenis is the newly appointed Anna Maria and Stephen Kellen Professor of Cancer Research and Professor of Pharmacology in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. He earned his B. A. from University of California, Berkeley in 1977 and his Ph.D. from Michigan State University in 1983. His postdoctoral research in the Department of Cellular and Developmental Biology at Harvard University was immediately followed by an appointment as Assistant Professor at Northwestern University Medical School in 1987. Dr. Blenis joined the faculty of Harvard Medical School as an Assistant Professor in 1989; he was promoted to Professor in 1996.
In the past 25 years as a faculty member, Dr. Blenis has trained or is currently training 40 postdoctoral fellows and 17 graduate students. Several of the past trainees are now in independent academic positions at major research universities and institutes including Yale University, University of Pennsylvania, University of Michigan, Seoul National University, Academia Sinica, Tufts University, University of Washington, Yeshiva University-Albert Einstein College of Medicine, the Van Andle Institute, University of Vermont, University of Montreal and University of Texas, Southwestern Medical Center. Several others hold senior positions in the biopharmaceutical industry. The Blenis Lab currently has 6 graduate students, 10 postdoctoral fellows, and 3 research assistants.
Dr. Blenis' honors include the ACS Junior Faculty award, AHA Established Investigator award, the LAM Foundation Established Investigator award and the NIH/NCI MERIT award.